Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Trillium Therapeutics Inc. T.TRIL

Trillium Therapeutics Inc is a clinical-stage immuno-oncology company that is engaged in developing therapies for the treatment of cancer. It has two clinical programs, TTI-621 and TTI-622, that target CD47. The company operates in the United States and Canada.


TSX:TRIL - Post by User

Bullboard Posts
Post by leclad5on Aug 10, 2010 8:35am
469 Views
Post# 17336603

Any Comments?

Any Comments?

CALGARY, ALBERTA, Aug 10, 2010 (MARKETWIRE via COMTEX) -- Stem Cell Therapeutics Corp. ("SCT" or the "Company") /quotes/comstock/11v!sss (CA:SSS0.07, 0.00, 0.00%) wishes to announce that Mark Wayne and Ian Brown have resigned as directors of the Company effective August 9th, 2010. The Company would like to thank both Mark Wayne and Ian Brown for their time and efforts as directors.

The Company has appointed, subject to TSXV approval, R. Dean Peterson and Dan Stearne as directors as of August 9th, 2010. Dean Peterson and Dan Stearne are both Calgary businessmen. Mr. Peterson is the founder of a company specializing in pipeline construction. Dan Stearne is president and CEO of Inventronics Limited a custom designer and manufacturer of metal enclosures intended for application in utility-type infrastructures. Dean Peterson is a significant shareholder of SCT owning directly and indirectly approximately 10% of SCT's common shares.

Bullboard Posts